[1] |
ORONSKY B, LARSON C, HAMMOND T C,et al. A review of persistent post-COVID syndrome(PPCS)[J]. Clinic Rev Allerg Immunol, 2023, 64(1):66-74. DOI: 10.1007/s12016-021-08848-3.
|
[2] |
TAQUET M, GEDDES J R, HUSAIN M,et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19:a retrospective cohort study using electronic health records[J]. Lancet Psychiatry, 2021, 8(5):416-427. DOI: 10.1016/S2215-0366(21)00084-5.
|
[3] |
|
[4] |
TAQUET M, LUCIANO S, GEDDES J R,et al. Bidirectional associations between COVID-19 and psychiatric disorder:retrospective cohort studies of 62 354 COVID-19 cases in the USA[J]. Lancet Psychiatry, 2021, 8(2):130-140. DOI: 10.1016/S2215-0366(20)30462-4.
|
[5] |
GALVIN J E, ROE C M, POWLISHTA K K,et al. The AD8:a brief informant interview to detect dementia[J]. Neurology, 2005, 65(4):559-564. DOI: 10.1212/01.wnl.0000172958.95282.2a.
|
[6] |
中国政府网. 关于印发新型冠状病毒肺炎诊疗方案(试行第八版 修订版)的通知[A/OL].(2021-04-14)[2023-01-19].
|
[7] |
SPITZER R L, KROENKE K, WILLIAMS J B W,et al. A brief measure for assessing generalized anxiety disorder:the GAD-7[J]. Arch Intern Med, 2006, 166(10):1092-1097. DOI: 10.1001/archinte.166.10.1092.
|
[8] |
LI H H, WANG L, SHI Z B,et al. Diagnostic utility of the PTSD Checklist in detecting ptsd in Chinese earthquake victims[J]. Psychol Rep, 2010, 107(3):733-739. DOI: 10.2466/03.15.20.PR0.107.6.733-739.
|
[9] |
LAM C L K, TSE E Y Y, GANDEK B,et al. The SF-36 summary scales were valid,reliable,and equivalent in a Chinese population[J]. J Clin Epidemiol, 2005, 58(8):815-822. DOI: 10.1016/j.jclinepi.2004.12.008.
|
[10] |
MISHRA G D, HOCKEY R, DOBSON A J. A comparison of SF-36 summary measures of physical and mental health for women across the life course[J]. Qual Life Res, 2014, 23(5):1515-1521. DOI: 10.1007/s11136-013-0586-3.
|
[11] |
方积乾. 生存质量测定方法及应用[M]. 北京:北京医科大学出版社,2000.
|
[12] |
|
[13] |
FERRUCCI R, DINI M, ROSCI C,et al. One-year cognitive follow-up of COVID-19 hospitalized patients[J]. Euro J Neurology, 2022, 29(7):2006-2014. DOI: 10.1111/ene.15324.
|
[14] |
|
[15] |
MÉNDEZ R, BALANZÁ-MARTÍNEZ V, LUPERDI S C,et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors[J]. J Intern Med, 2021, 290(3):621-631. DOI: 10.1111/joim.13262.
|
[16] |
DELGADO-ALONSO C, VALLES-SALGADO M, DELGADO-ÁLVAREZ A,et al. Cognitive dysfunction associated with COVID-19:a comprehensive neuropsychological study[J]. J Psychiatr Res, 2022, 150:40-46. DOI: 10.1016/j.jpsychires.2022.03.033.
|
[17] |
MÉNDEZ R, BALANZÁ-MARTÍNEZ V, LUPERDI S C,et al. Long-term neuropsychiatric outcomes in COVID-19 survivors:a 1-year longitudinal study[J]. J Intern Med, 2022, 291(2):247-251. DOI: 10.1111/joim.13389.
|
[18] |
DAMIANO R F, GUEDES B F, DE ROCCA C C,et al. Cognitive decline following acute viral infections:literature review and projections for post-COVID-19[J]. Eur Arch Psychiatry Clin Neurosci, 2022, 272(1):139-154. DOI: 10.1007/s00406-021-01286-4.
|
[19] |
SOLOMON I H, NORMANDIN E, BHATTACHARYYA S,et al. Neuropathological features of covid-19[J]. N Engl J Med, 2020, 383(10):989-992. DOI: 10.1056/NEJMc2019373.
|
[20] |
MUCCIOLI L, PENSATO U, CANI I,et al. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation[J]. Ann Neurol, 2020, 88(4):860-861. DOI: 10.1002/ana.25855.
|
[21] |
MEINHARDT J, RADKE J, DITTMAYER C,et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19[J]. Nat Neurosci, 2021, 24(2):168-175. DOI: 10.1038/s41593-020-00758-5.
|
[22] |
FERRETTI L, MCCURRY S M, LOGSDON R,et al. Anxiety and alzheimer's disease[J]. J Geriatr Psychiatry Neurol, 2001, 14(1):52-58. DOI: 10.1177/089198870101400111.
|
[23] |
MENDEZ M F. The relationship between anxiety and alzheimer's disease[J]. J Alzheimers Dis Rep, 2021, 5(1):171-177. DOI: 10.3233/adr-210294.
|
[24] |
梁小妞,丁玎,罗剑锋,等. 焦虑和抑郁症状与老年极早期认知功能障碍的相关性研究[J]. 中国临床神经科学,2015,23(6):635-641.
|
[25] |
SANTABÁRBARA J, VILLAGRASA B, LÓPEZ-ANTÓN R,et al. Clinically relevant anxiety and risk of Alzheimer's disease in an elderly community sample:4.5 years of follow-up[J]. J Affect Disord, 2019, 250:16-20. DOI: 10.1016/j.jad.2019.02.050.
|
[26] |
RICHMOND-RAKERD L S, D'SOUZA S, MILNE B J,et al. Longitudinal associations of mental disorders with dementia[J]. JAMA Psychiatry, 2022, 79(4):333. DOI: 10.1001/jamapsychiatry.2021.4377.
|
[27] |
HENDRY K, GREEN C, MCSHANE R,et al. AD-8 for detection of dementia across a variety of healthcare settings[J]. Cochrane Database Syst Rev, 2019, 3(3):CD011121. DOI: 10.1002/14651858.CD011121.pub2.
|
[28] |
HALPIN S J, MCIVOR C, WHYATT G,et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection:a cross-sectional evaluation[J]. J Med Virol, 2021, 93(2):1013-1022. DOI: 10.1002/jmv.26368.
|